IVVD Q2 2025 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+420.6% YoY

Gross Profit

$11M94.2% margin

Operating Income

-$15M-127.8% margin

Net Income

-$15M-124.4% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$89M

Total Liabilities

$46M

Stockholders' Equity

$43M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$2M	+420.6%
Gross Profit	$11M	$2M	+410.2%
Operating Income	-$15M	-$49M	+69.4%
Net Income	-$15M	-$47M	+69.0%

Revenue Segments

Product

$12M100%